Table 1.
Year | First author | Country | Study design | Patients (n) | Age median | NOS | Cut off value NLR |
2018 | Zhang LX | China | R | 904 | N/A | 7 | 2 |
2016 | Pang W | China | R | 927 | 63 | 7 | 1.59 |
2017 | Song S | China | P | 1990 | 62 | 5 | 2.10 |
2015 | Yu L | China | R | 291 | N/A | 8 | 3.5 |
2015 | Kim EY | S. Korea | P | 1986 | 58.2 | 6 | 3 |
2014 | Jiang N | China | R | 377 | 64 | 6 | 1.44 |
2015 | Hsu JT | Taiwan | R | 1030 | N/A | 6 | 3.44 |
2010 | Ubukata H | Japan | R | 157 | 65 | 6 | 5 |
2010 | Shimada H | Japan | R | 1028 | 65 | 5 | 4 |
2018 | Zhang Y | China | P | 182 | 65 | 7 | 2.88 |
2018 | Mori M | Japan | R | 100 | 66 | 6 | 1 |
2019 | Kosuga T | Japan | R | 429 | 67 | 7 | 1.6 |
9401 |
NLR = neutrophil to lymphocyte ratio, NOS = Newcastle Ottawa Scale, P = prospective, R = retrospective.